Use of anakinra in severe COVID-19: A case report

被引：55
|
作者：
Filocamo, Giovanni [1 ]
Mangioni, Davide [1 ,2 ,3 ]
Tagliabue, Paola [1 ,4 ]
Aliberti, Stefano [1 ,2 ,5 ,6 ]
Costantino, Giorgio [1 ,2 ,7 ]
Minoia, Francesca [1 ,8 ]
Bandera, Alessandra [1 ,2 ,3 ]
机构：
[1] Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Milan, Italy
[2] Univ Milan, Milan, Italy
[3] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Internal Med, Infect Dis Unit,Dept Pathophysiol & Transplantat, Via Francesco Sforza 35, I-20122 Milan, Italy
[4] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Anesthesia Reanimat & Urgent Emergency Care, Via Francesco Sforza 35, I-20122 Milan, Italy
[5] Univ Milan, Internal Med Dept, Dept Pathophysiol & Transplantat, Resp Unit, Via Francesco Sforza 35, I-20122 Milan, Italy
[6] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Cyst Fibrosis Adult Ctr, Via Francesco Sforza 35, I-20122 Milan, Italy
[7] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Unita Operat Complessa Pronto Soccorso & Med Urge, Via Francesco Sforza 35, I-20122 Milan, Italy
[8] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Pediat Medium Intens Care Unit, Pediat Rheumatol, Clin Marchi, Via Commenda 9, I-20123 Milan, Italy
来源：
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES | 2020年 / 96卷
关键词：
Anakinra; IL-1; COVID-19; Treatment; Biologic;
D O I：
10.1016/j.ijid.2020.05.026
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Coronavirus disease 19 is a global healthcare emergency with a high lethality rate. Relevant inflammatory cytokine storm is associated with severity of disease, and IL-1 inhibition is a cornerstone treatment for hyperinflammatory diseases. We present here the case of a patient with critical COVID-19 successfully treated with IL-1 receptor antagonist (anakinra). (C) 2020 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
引用
收藏
页码：607 / 609
页数：3
相关论文
共 50 条
  • [41] Anakinra: a silver lining in COVID-19?
    Rahul Gupta
    Critical Care, 24
  • [42] Effect of anakinra in COVID-19 Reply
    Cavan, Giulio
    Dagno, Lorenzo
    LANCET RHEUMATOLOGY, 2020, 2 (09): : E524 - E525
  • [43] Anakinra: a silver lining in COVID-19?
    Gupta, Rahul
    CRITICAL CARE, 2020, 24 (01)
  • [44] Cytomegalovirus meningoencephalitis in a case of severe COVID-19 Pneumonia. A case report
    Ananthegowda, Dore C.
    Khatib, Mohamad Y.
    Ali, Husain S.
    Al Wraidat, Mohamed
    Imam, Yahia
    IDCASES, 2021, 26
  • [45] PREDICTORS OF MORTALITY IN SEVERE AND CRITICAL COVID-19 PATIENTS WHO RECEIVED ANAKINRA
    Bektas, M.
    Kilic, M. I.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 948 - 948
  • [46] Anakinra for the Treatment of COVID-19-Associated Pericarditis: A Case Report
    Karadeniz, Hazan
    Yamak, Betul Ayca
    Ozger, Hasan Selcuk
    Sezenoz, Burak
    Tufan, Abdurrahman
    Emmi, Giacomo
    CARDIOVASCULAR DRUGS AND THERAPY, 2020, 34 (06) : 883 - 885
  • [47] Comparison of anakinra and tocilizumab in management of severe COVID-19: a retrospective cohort study
    Kucuksahin, Orhan
    Erden, Abdulsamet
    Karakas, Ozlem
    Guven, Serdar Can
    Armagan, Berkan
    Sahiner, Enes Seyda
    Inan, Osman
    Kurtipek, Ali Can
    Gemcioglu, Emin
    Karaahmetoglu, Selma
    Turan, Sema
    Izdes, Seval
    Erdem, Deniz
    Aypak, Adalet
    Ayhan, Muge
    Akinci, Esragul
    Bodur, Hurrem
    Guner, Rahmet
    Omma, Ahmet
    Ates, Ihsan
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2022, 52 (05) : 1486 - 1494
  • [48] Anakinra for the Treatment of COVID-19-Associated Pericarditis: A Case Report
    Hazan Karadeniz
    Betül Ayça Yamak
    Hasan Selçuk Özger
    Burak Sezenöz
    Abdurrahman Tufan
    Giacomo Emmi
    Cardiovascular Drugs and Therapy, 2020, 34 : 883 - 885
  • [49] Favorable Anakinra Responses in Severe Covid-19 Patients with Secondary Hemophagocytic Lymphohistiocytosis
    Dimopoulos, George
    de Mast, Quirijn
    Markou, Nikolaos
    Theodorakopoulou, Maria
    Komnos, Apostolos
    Mouktaroudi, Maria
    Netea, Mihai G.
    Spyridopoulos, Themistoklis
    Verheggen, Rebecca J.
    Hoogerwerf, Jacobien
    Lachana, Alexandra
    van de Veerdonk, Frank L.
    Giamarellos-Bourboulis, Evangelos J.
    CELL HOST & MICROBE, 2020, 28 (01) : 117 - +
  • [50] Proposal for the use of anakinra in acute respiratory distress secondary to COVID-19
    Munoz-Jimenez, Alejandro
    Rubio-Romero, Esteban
    de la Fuente, Jose Luis Marenco
    REUMATOLOGIA CLINICA, 2020, 17 (06): : 309 - 312
12345